Skip to main content

Search articles in Manufacturing

Found 9 articles

  • Just – Evotec Biologics selected by U.S. Departmen

    Just – Evotec Biologics selected by U.S. Department of Defense for Manufacturing Optimization Program

    • 25 Jun 2024
    • Editor

    Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced that its Seattle-based subsidiary, Just – Evotec Biologics, Inc., was selected by the U.S. Department of Defense (“DOD”) to develop an accelerated monoclonal antibody (“mAb”) development and manufacturing solution for the DOD’s Manufacturing Optimization Program.

  • Novo Nordisk announces 4.1 billion USD investment

    Novo Nordisk announces 4.1 billion USD investment to expand US manufacturing capacity adline

    • 25 Jun 2024
    • Editor

    Novo Nordisk today announced plans to invest 4.1 billion US dollars (approx 27 billion Danish kroner) to build a second fill and finishing manufacturing facility in Clayton, North Carolina, and grow its ability to produce current and future injectable treatments for people with obesity and other serious chronic diseases.

  • Eckert & Ziegler and UJF Open State-of-the-Art Act

    Eckert & Ziegler and UJF Open State-of-the-Art Actinium-225 Production Facility

    • 19 Jun 2024
    • Editor

    Eckert & Ziegler Radiopharma GmbH (Eckert & Ziegler), in collaboration with the Nuclear Physics Institute of the Czech Academy of Sciences (Ústav jaderné fyziky, “UJF”), announces the grand opening of a pioneering Actinium-225 (Ac-225) production facility.

  • Thermo Fisher Scientific Opens New GMP-certified U

    Thermo Fisher Scientific Opens New GMP-certified Ultra-cold Facility in the EU to Accelerate Advanced Therapies Development

    • 3 Jun 2024
    • Editor

    Thermo Fisher Scientific Inc., the world leader in serving science, has opened a new clinical and commercial ultra-cold facility in the EU, expanding its clinical trial network in Europe to help accelerate the development of advanced therapies.

  • Sanofi adds over €1 billion for biomanufacturing t

    Sanofi adds over €1 billion for biomanufacturing to €2.5 billion already committed in major projects in France to support health sovereignty

    • 14 May 2024
    • Editor

    As the largest private contributor to the security and independence of France's health ecosystem, Sanofi today announces an investment of more than €1 billion to create new bioproduction capacity at its sites in Vitry-sur-Seine (Val de Marne), Le Trait (Seine-Maritime) and Lyon Gerland (Rhône).

  • Bristol Myers Squibb and Cellares Announce a $380M

    Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the Manufacture of CAR T Cell Therapies to Bring the Promise of Cell Therapy to More Patients, Faster

    • 23 Apr 2024
    • Editor

    Bristol Myers Squibb (NYSE: BMY) and Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing, today announced a worldwide capacity reservation and supply agreement for the manufacture of CAR T cell therapies in a transaction valued up to $380M in upfront and milestone payments.

  • Lilly Acquires New Injectable Medicine Manufacturi

    Lilly Acquires New Injectable Medicine Manufacturing Facility from Nexus Pharmaceuticals

    • 23 Apr 2024
    • Editor

    Eli Lilly and Company (NYSE: LLY) and Nexus Pharmaceuticals, LLC today announced a definitive agreement for Lilly to acquire a manufacturing facility from Nexus, a leading sterile manufacturer in the pharmaceutical industry.

  • Takeda Recognized with 2024 ISPE Facility of the Y

    Takeda Recognized with 2024 ISPE Facility of the Year Awards in Category Operations

    • 17 Apr 2024
    • Editor

    Takeda (TSE:4502/NYSE:TAK) today announced that the International Society for Pharmaceutical Engineering (ISPE) has awarded the company top honors in the category Operations with the 2024 Facility of the Year Awards (FOYA).

  • Molex Expands European Manufacturing Footprint and

    Molex Expands European Manufacturing Footprint and Capabilities with State-of-the-Art Campus in Poland

    • 9 Nov 2023
    • Editor

    Molex, a global electronics leader and connectivity innovator, today announced a major expansion of its global manufacturing footprint with the opening of a new campus in Katowice, Poland.